A phase 2 double-blind placebo-controlled 24-week treatment clinical study of the p38 alpha kinase inhibitor neflamapimod in mild Alzheimer’s disease
ALZHEIMERS RESEARCH & THERAPY（2021）
关键词
p38 MAPK, Alzheimer's, Episodic memory, Clinical trial, CSF biomarkers, Synaptic dysfunction
AI 理解论文
溯源树
样例
生成溯源树，研究论文发展脉络
Chat Paper
正在生成论文摘要